White House to press forward with FDA nominee despite US Senate chairman’s concerns

By: Jennifer Shutt

Outlets: DC Bureau (States Newsroom)

Published: August 20, 2026

Words: 487

Last Updated: 2 months ago

Body Text Preview

WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration will face challenges securing Senate confirmation after the committee chairman in charge of that process expressed doubts.

That, however, hasn’t deterred White House officials from pressing for Dr. Heidi Overton, arguing she has the experience needed and that her policy goals align with the president's.

“As Deputy Assistant to the President for Domestic Policy, Dr. Heidi Overton has spent the last year …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us